Chromatographic analysis of dopamine metabolism in a Parkinsonian model

Journal of Chromatography A

Volumn 1120, Issue 1-2, 2006, Pages 13-20

  Baranyi, Mária ^a   Milusheva, Elisaveta ^b   Vizi, E Sylvester ^a   Sperlágh, Beáta ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Dopamine metabolism; Dopamine quinone; Endogenous; Multi dimensional analysis; Neurotransmitter release

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; DISEASES; MATHEMATICAL MODELS; METABOLISM; METABOLITES; OXIDATION;

DOPAMINE METABOLISM; DOPAMINE QUINONE; ENDOGENOUS; MULTI DIMENSIONAL ANALYSIS; NEUROTRANSMITTER RELEASE;

PHARMACODYNAMICS;

DOPAMINE; HYDROGEN; QUINONE DERIVATIVE; ROTENONE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; ION PAIR CHROMATOGRAPHY; MALE; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY;

ADENINE NUCLEOTIDES; ANIMALS; CATECHOLAMINES; CHROMATOGRAPHY, LIQUID; CORPUS STRIATUM; DOPAMINE; INSECTICIDES; MALE; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE;

PARKINSONIA;

EID: 33744983486     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2006.03.018     Document Type: Article

References (24)

1. Glowinski J., and Iversen L.L. J. Neurochem. 13 (1966) 655
2. Crossman A.R. Comp. Biochem. Physiol. A 93 (1989) 141
3. Graham D.G. Mol. Pharmacol. 14 (1978) 633
4. Verhage M., Hens J.J.H., De Graan P.N.E., Boomsma F., Wiegant V.M., da Silva F.H.L., Gispen W.H., and Ghijsen W.E.J.M. Eur. J. Pharmacol. Mol. Pharmacol. 291 (1995) 387
5. Baranyi M., Dóda M., Földes F., Tuba Z., Vizi E.S., and Földes F.F. 1st EPHAR Congress, Milan. Pharmacol. Res. 31 (1995) 37
6. Sperlágh B., Zsilla G., Baranyi M., Kékes-Szabó A., and Vizi E.S. Int. J. Dev. Neurosci. 15 (1997) 739
7. Bencsics A., Sershen H., Baranyi M., Hashim A., Lajtha A., and Vizi E.S. Brain Res. 761 (1997) 236
8. M. Baranyi, E. Milusheva, T. Nakai, B. Sperlágh, E.S. Vizi, Joint Meeting the Physiological Society of United Kingdom with Hungarian Physiological Society, Budapest, J. Physiol. Lond. 131 (2001) 27.
9. Lendvai B., Sershen H., Santha E., Baranyi M., and Vizi E.S. Neuropharmacology 35 (1996) 1769
10. Milusheva E., Sperlágh B., Shikova L., Baranyi M., Tretter L., Ádám-Vizi V., and Vizi E.S. Neuroscience 120 (2003) 771
11. Wooten G.F. Neurochemistry and Neuropharmacology of Parkinson's Disease (1997), McGraw-Hill, New York pp. 153
12. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Nat. Neurosci. 3 (2000) 1301
13. S.W., T. Li Lin, S. Minteer, W.J. Burke, Mol. Brain Res. 93 (2001) 1.
14. Berman S.B., and Hastings T.S. J. Neurochem. 73 (1999) 1127
15. Graham D.G. Mol. Pharmacol. 14 (1978) 633
16. Nappi A.J., and Vass E. J. Biol. Chem. 276 (2001) 11214
17. Li S.W., Spaziano V.T., and Burke W.J. Bioorg. Chem. 26 (1998) 45
18. Smith J.D. Methods in Enzymology vol. 112 (1967), Academic Press, New York p. 35
19. Hawley M.D., Tatawawadi S., Piekarski S.V., and Adams R.N. J. Am. Chem. Soc. 89 (1967) 447
20. Halliwell B. J. Neurochem. 59 (1992) 1609
21. Hastings T.G. J. Neurochem. 64 (1995) 919
22. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Nature 388 (1997) 839
23. Antunes F., Nunes C., Laranjinha J., and Cadenas E. Toxicology 208 (2005) 207
24. Tse D.C.S., McCreery R.L., and Adams R.N. J. Med. Chem. 19 (1976) 37